| Literature DB >> 35749515 |
Jianguang Du1, Qun Wang1, Shuangshuang Yang1,2, Si Chen1,3, Yongyao Fu2, Sabine Spath4, Phillip Domeier4, David Hagin5,6,7, Stephanie Anover-Sombke5,6,7, Maya Haouili1, Sheng Liu8, Jun Wan8, Lei Han1, Juli Liu1, Lei Yang1, Neel Sangani9,10, Yujing Li8, Xiongbin Lu8, Sarath Chandra Janga8,9,10, Mark H Kaplan2, Troy R Torgerson5,6,7, Steven F Ziegler4, Baohua Zhou1,2.
Abstract
Differing from the mouse Foxp3 gene that encodes only one protein product, human FOXP3 encodes two major isoforms through alternative splicing-a longer isoform (FOXP3 FL) containing all the coding exons and a shorter isoform lacking the amino acids encoded by exon 2 (FOXP3 ΔE2). The two isoforms are naturally expressed in humans, yet their differences in controlling regulatory T cell phenotype and functionality remain unclear. In this study, we show that patients expressing only the shorter isoform fail to maintain self-tolerance and develop immunodeficiency, polyendocrinopathy, and enteropathy X-linked (IPEX) syndrome. Mice with Foxp3 exon 2 deletion have excessive follicular helper T (TFH) and germinal center B (GC B) cell responses, and develop systemic autoimmune disease with anti-dsDNA and antinuclear autoantibody production, as well as immune complex glomerulonephritis. Despite having normal suppressive function in in vitro assays, regulatory T cells expressing FOXP3 ΔE2 are unstable and sufficient to induce autoimmunity when transferred into Tcrb-deficient mice. Mechanistically, the FOXP3 ΔE2 isoform allows increased expression of selected cytokines, but decreased expression of a set of positive regulators of Foxp3 without altered binding to these gene loci. These findings uncover indispensable functions of the FOXP3 exon 2 region, highlighting a role in regulating a transcriptional program that maintains Treg stability and immune homeostasis.Entities:
Mesh:
Substances:
Year: 2022 PMID: 35749515 PMCID: PMC9333337 DOI: 10.1126/sciimmunol.abo5407
Source DB: PubMed Journal: Sci Immunol ISSN: 2470-9468